Curaleaf Holdings Inc.
CURA,
responded late Friday to reports it was among those interested in buying Canadian cannabis company Cronos Inc.
CRON,
Curaleaf said the Canadian Investment Regulatory Organization had requested a comment on market speculation. “As previously disclosed, the company regularly examines transactions including partnerships, possible acquisitions, sales and mergers with third parties,” the company said in a statement. “There is no guarantee that any potential transaction will materialize.” Earlier Friday, Curaleaf said it did not comment on market speculation about reports of a transaction unless required by law. Shares of Curaleaf closed Friday up nearly 16%, while Cronos shares finished up nearly 7%.
Read the full article here